Matthew I. Milowsky

1 ta ish

University of North Carolina at Chapel Hill

1. Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer

   Karen A. Autio, Robert Dreicer, Justine Anderson +13

   MaqolaOAOchiq kirish20183 iqtibos

   ABIABI:AkademIndex/2026.other.051877